Human collagen III mRNA therapy for effective skin rejuvenation.

Jiamin Zhang, Shuqi Chen, Jiaqi Yang, Lianhao Song, Linfeng Chen, Wei Feng, Rong Ju, Zhi Xie

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-sen University, Guangzhou, 510060, China.State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-sen University, Guangzhou, 510060, China. · pubmed

Paper

Abstract

Skin photoaging leads to the deterioration of dermal collagen and overall skin integrity, resulting in visible signs of aging, particularly around the eye. Collagen III plays a pivotal role in maintaining skin elasticity and facilitating proper collagen fibril organization. Messenger RNA (mRNA)-based therapeutics present a novel alternative for addressing these limitations by enabling the localized production of full-length, biologically active proteins.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that mRNA therapy targeting collagen III can rejuvenate skin by enhancing collagen production. This research is relevant as it addresses a fundamental aspect of skin aging, focusing on restoring collagen levels, which is a key factor in the aging process.

Author of this paper? Send a correction.